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Abstract: Genetic variants that result in truncation in desmoplakin (DSP) are a known cause of
arrhythmogenic cardiomyopathy (AC). In homozygous carriers, the combined involvement of skin
and heart muscle is well defined, however, this is not the case in heterozygous carriers. The aim of
this work is to describe cutaneous findings and analyze the molecular and ultrastructural cutaneous
changes in this group of patients. Four women and eight men with a mean age of 48 ± 14 years
were included. Eight met definitive criteria for AC, one was borderline and three were silent carriers.
No relevant macroscopic changes in skin and hair were detected. However, significantly lower skin
temperature (29.56 vs. 30.97 ◦C, p = 0.036) and higher transepidermal water loss (TEWL) (37.62 vs.
23.95 g m 2 h 1, p = 0.028) were observed compared to sex- and age-matched controls. Histopathology
of the skin biopsy showed widening of intercellular spaces and acantholysis of keratinocytes in the
spinous layer. Immunohistochemistry showed a strongly reduced expression of DSP in all samples.
Trichogram showed regular nodules (thickening) compatible with pseudomonilethrix. Therefore,
regardless of cardiac involvement, heterozygous patients with truncation-type variants in DSP have
lower skin temperature and higher TEWL, constant microscopic skin involvement with specific
patterns and pseudomonilethrix in the trichogram.
Keywords: arrhythmogenic-cardiomyopathy; desmoplakin; skin-homeostasis; keratinocytes; pseu-
domolinethrix
1. Introduction
Arrhythmogenic cardiomyopathy (AC) is an inherited myocardial disease that pre-
disposes to fibrofatty replacement, ventricular aneurysms and sudden cardiac death due
to ventricular arrhythmias [1]. This disease is one of the leading causes of sudden cardiac
death due to ventricular tachyarrhythmias, especially in people under 35 years of age and
in athletes. The first genetic variants associated with this condition were described in genes
encoding desmosomes, critical structures involved in adherence regulation and mechanical
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integrity of tissues, especially in the myocardium and the skin. Familial characterization
of this disease as a genetically conditioned disorder of desmosomes was first made by
studying patients with Naxos disease, an autosomal recessive cardiocutaneous syndrome
caused by mutations in plakoglobin and featured by the presence of AC, palmoplantar
hyperkeratosis and „woolly” hair [2]. Carvajal disease was later described as another reces-
sive cardiocutaneous syndrome, in this case by mutations in desmoplakin (DSP). However,
mutations in desmosomal genes with autosomal dominant inheritance have classically
been described to cause an exclusive cardiac phenotype without skin involvement [3]. The
published series have shown that heterozygous carriers can develop as severe heart disease
as homozygotes, although in heterozygosis the penetrance of the disease is incomplete. The
causes of this incomplete penetrance are not yet fully understood. The age at onset of AC
is variable with an estimated mean age of 31 years, being rare after the age of 60 years [4].
Gender disparity in the phenotypic presentation of AC has been demonstrated in differ-
ent studies, highlighting male sex as a risk factor for the development of life-threatening
arrhythmias [5].
Furthermore, cutaneous keratinocytes have been shown to express all cardiac isoforms
of desmosomal proteins [6–8]. These findings support the hypothesis that they may
reflect the molecular and histological changes that occur in the myocardium of patients
affected by AC. Moreover, cutaneous involvement has recently been observed in a cohort
of heterozygous patients with AC and truncating DSP variants [9].
The aim of this study is to describe cutaneous findings and analyze the molecular and
ultrastructural cutaneous changes in heterozygous DSP truncating variant carriers with
AC. The finding of specific patterns of cutaneous and hair involvement could potentially
identify new patients, even in the absence of macroscopic cardiac involvement.
2. Materials and Methods
2.1. Patients
Patients with AC and a truncating DSP variant were selected from the Inherited
Cardiovascular Diseases Unit of our center. Eight of the patients fulfilled current AC
Task Force criteria (TFC) for left-sided or biventricular cardiomyopathy [10], one was
identified as borderline and three cases were considered silent carriers. A complete car-
diological study, including an electrocardiogram (ECG), 24 h-ambulatory ECG, exercise
test, echocardiogram and cardiac magnetic resonance (CMR) was performed to assess
the cardiac phenotype. Genetic test ruled out any other genetic variants and complex
inheritance patterns. Pathogenicity of genetic variants was classified according to the
American Academy [11], taking into account frequency in public databases (including the
Human Gene Mutation Database, Single Nucleotide Polymorphism Database, NHLBI GO
Exome Sequencing Project and ClinVar or in the Exome Aggregation Consortium (ExAC)
database), its previous literature description, and several bioinformatic predictions accord-
ing to its localization and conservation. After identification of DSP pathogenic variants in
the unrelated index patients, we performed a genetic cascade screening among all avail-
able relatives using Sanger DNA sequencing method. Phenocopies such as myocarditis,
sarcoidosis or ischemic heart disease were reasonably ruled out.
2.2. Dermatological Evaluation and Skin Barrier Function Assessment
Two independent dermatologists evaluated skin alterations and scalp disorders in
the patients. Plucked hair shafts were collected to perform a trichogram. Homeostasis
parameters related to epidermal barrier function were also measured. Transepidermal
water loss (in g·m−2·h−1, using Tewameter® TM 300), stratum corneum hydration (in
arbitrary units (AU), using Corneometer® CM 825), pH (using Skin-pH-Meter® PH 905),
erythema and melanin index (in AU, using Mexameter® MX 18) and skin temperature
(in ◦C, using Skin-Thermometer ST 500) were measured by a Multi Probe Adapter (MPA,
Courage + Khazaka electronic GmbH, Bilbao, Spain). All variables were measured ten
times, using their average for analysis. All these measurements were taken following the
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same order. All measurements were taken in the same room at a mean room temperature
of 23 ± 1 ◦C and ambient air humidity of 45% (range, 40–50%). All participants underwent
an adaptation period of at least 20 min before the measurements were taken. No systemic
or topical treatments were allowed 3 hours before the measurements were taken. These
variables were measured at three body sites: the right volar forearm, an involved area
on the right palm and a non-involved area on the right palm. If the patient did not have
skin manifestation, measurements were only taken on the right volar forearm and on the
right palm.
Healthy controls gender- and age-matched (±3 years) with patients were also mea-
sured on the right volar forearm and on the right palm. These volunteers were people
who attended the Dermatology Department for trivial conditions such as melanocytic nevi
or seborrheic keratoses and did not suffer from an inflammatory skin disease, such as
psoriasis or atopic dermatitis.
2.3. Samples Processing
A cutaneous biopsy was taken from non lesional skin from the palm of the hand in all
cases. Samples were fixed in formaldehyde 10%, cut, processed and included in paraffin.
Then, 2 µm sections were obtained on high adhesion slides. The deparaffination plus
antigen retrieval was automatically performed using the PTLink from Agilent Dako. The
immunostaining was performed in the AutostainerLink 48 from Dako. The slides were
revealed with diaminobenzidine and counterstained with hematoxylin. Sample 12 was not
valid for immunohistochemical or hematoxylin-eosin study.
2.4. Immunohistochemistry
Skin biopsies were studied with hematoxylin-eosin and subsequently an immunohis-
tochemical study was performed to assess the cutaneous expression of different proteins.
Information of the antibodies used, the manufacturers as well as the conditions used during
the immunohistochemical procedure is included in the Table A1 of Appendix A. Biopsies
from our archives from patients without disease (normal skin) were used as controls.
2.5. Transmission Electron Microscopy
Skin samples were fixed and embedded according to standard protocols. The tissue
sample was fixed by immersion in 2% glutaraldehyde in 0.1 M cacodylate buffer (PB),
pH 7.4, for 4 h at 4 ◦C. After fixation, the samples were rinsed three times with 0.1 M
cacodylate buffer (PB), pH 7.4, for 15 min at 4 ◦C and stored overnight until further
processing. Subsequently, the samples were postfixed with 0.1% osmium tetroxide in 0.1 M
PB, pH 7.2, containing 1% potassium ferrocyanide for 1 h at 4 ◦C, dehydrated in a graded
series of alcohols and embedded in epoxy resin. Semithin sections (500 nm) were stained
with toluidine blue for light microscopic examination. Ultrathin sections were stained with
uranyl acetate and lead citrate and analyzed under a Zeiss LEO 906E transmission electron
microscope (Zeiss, Oberkochem, Germany).
2.6. Statistical Analysis
Descriptive statistics were used to present the sample characteristics. Continuous data
was expressed as the mean ± standard deviation. The absolute and relative frequency
distributions were estimated for qualitative variables. The Shapiro–Wilk test was used
to check the normality of data distribution and Levene’s test to check the homogeneity
of variance. The Student’s t-test for independent samples or Welch’s test was used to
compare homeostasis parameters between patients and controls. The Student’s t-test for
independent samples was used to compare homeostasis parameters between affected and
non-affected areas in the same subject. A p-value of ≤ 0.05 was considered statistically
significant. Statistical Analyses were performed using the SPSS package (SPSS for Windows,
Version 24.0 Chicago: SPSS Inc.).
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3. Results
Twelve heterozygous carriers of genetic variants leading to truncation in DSP from
seven different families were included—four females (33%) and eight males (66%)—with
a mean age of 48 ± 14 years. Eight patients met definitive criteria for the diagnosis
of AC according to the 2010 TFC: two with exclusive left ventricular involvement, two
with right ventricular involvement and four with biventricular involvement. Most of
these cases showed segregation of the DSP mutation with a phenotype consisting of left
ventricular fibrofatty replacement, low QRS complex voltages and an increased arrhythmic
risk (Figure A1 of Appendix B). Patients 4, 6 and 9 had no pathological findings on ECG,
echocardiogram or CMR, did not present events during follow-up, and were classified as
silent carriers. Finally, one case showed a borderline AC status according to the TFC. A
summary of the baseline cardiac phenotype of the enrolled patients is included in Table 1.















Patient 1 24 Female p.Asp960Glnfs*16 55 Borderline Subepicardialpatching in LV 102 No No
Patient 2 28 Male p.Arg2284* 50 Definitive
Subepicardial
circumferential
in LV and RV
free wall
2916 No No





Patient 4 60 Male p.Arg2284* 58 Silentcarrier No 21 No No
Patient 5 48 Male p.Arg1045* 48 Definitive
Lineal
infero-lateral in
LV and RV free
wall
1544 No Yes
Patient 6 50 Male p.Arg1045* 60 Silentcarrier No 51 No No










Patient 9 31 Male p.Asp960Glnfs*16 55 Silentcarrier No 4 No No
Patient 10 62 Female p.Asp960Glnfs*16 57 Definitive No 474 No No
Patient 11 62 Male p.Ile228Hisfs*29 22 Definitive CMR could notbe performed 29234 No Yes
Patient 12 53 Female p.Val2567Cys.Fs* 60 Definitive No <500 No No
LVEF: left ventricle ejection fraction. TFC: Task Force criteria. VPB: ventricular premature beats. ECG: electrocardiogram. NSVT: non-
sustained ventricular tachycardia. SVA: sustained ventricular arrhythmia (sustained ventricular tachycardia, ventricular fibrillation,
cardiorespiratory arrest or appropriate shock). LV: left ventricle. RV: right ventricle. CMR: cardiac magnetic resonance.
3.1. Dermatological Evaluation and Skin Barrier Function Assessment
Clinically, only 33.33% (4/12) of patients had dermatological manifestations: 16.67%
(2/12) had androgenic alopecia, Ludwig grade I, and 16.67% hyperkeratosis in pressure
areas of the hands. Regarding skin barrier function (Table 2), we observed that transepider-
mal water loss was significantly higher on the patients’ palm than in controls’ (37.62 vs.
23.94 g·m−2·h−1, p = 0.028) while temperature was lower (29.56 vs. 30.97 ◦C, p = 0.036). No
differences in stratum corneum hydration, erythema, melanin or pH were found on the
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palm. Moreover, no differences in skin barrier function on the volar forearm were found
between patients and controls. Differences between the involved and the non-involved
area on the right palm were not observed in any skin barrier function parameter.
Table 2. Main histopathological findings.
Histopathological Findings (H&E) Immunohistochemistry




Sign Plakoglobin Filamin C Desmoplakin Conexin 43
1 No Focal Yes Yes Yes Yes Positive Positive Positiveweak Positive
2 No Focal Yes Yes Yes Yes Positive Positive Negative Positive
3 No No Yes Yes No Yes Positive Positive Negative Positive
4 No Focal Yes Yes No Yes Positive Positive Negative Positive
5 No No Yes Yes Yes Yes Positive Positive Positiveweak Positive
6 No No Yes Yes No Yes Positive Positive Positiveweak Positive
7 Yes No Yes Yes Yes Yes Positive Positive Negative Positive
8 Yes No Yes Yes Yes Yes Positive Positive Negative Positive
9 Yes No Yes Yes Yes Yes Positive Positive Negative Positive
10 No No Yes Yes Yes Yes Positive Positive Negative Positive
11 Yes No Yes Yes Yes Yes Positive Positive Negative Positive
12 * - - - - - - - - - -
P: patient. * Sample 12 was not valid for immunohistochemical or hematoxylin-eosin study.
3.2. Histopathology
Table 2 shows the main histopathological findings in each patient. The most remark-
able feature was a significant widening of the intercellular spaces of the keratinocytes,
which was evident in all the cases. This was most noticeable in the spinous layer and,
in consequence, the spines of the keratinocytes were more evident than usual. Focally,
acantholysis with separation of the keratinocytes from each other and open intercellular
clefts (Figure 1A), with evidence of round acantholytic cells (Figure 1B) were observed.
In all the analyzed cases, the keratinocytes showed a very unusual appearance, with a
striated cytoplasm which reminded the lines that shape fingerprints. For this reason, the
term ‘fingerprint sign’ has been proposed (Figure 2). In addition, papillomatosis, dysker-
atosis, transition cells, pale cytoplasm and cytoplasmic eosinophilic globules were absent.
3.3. Trichogram
All trichogram findings are summarized in the Table A2 of Appendix B. Some patients
showed a prominent shift towards catagen/telogen. There was no hair shaft dysplasia
or cuticular defects. However, seven showed non-uniform thickness of hair shafts and
pseudomonilethrix (Figure 1C).
3.4. Immunohistochemistry
The expression of Plakoglobin, Filamin C and Connexin 43 in the skin biopsies was
normal (Table 2). However, most of the patients showed negative results for desmoplakin
expression (Figure 1D) and only three of them (1, 5 and 6) showed weak expression
(Figure 1E).
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Figure 1. Main findings in the immunohistochemistry study. (A): acantholytic areas evidenced in case 9 (Hematoxylin-
Eosin ×200). (B): Acantholytic round cells. Some desmosomes (spines) are still observed between the round cells and ad-
jacent keratinocytes (hematocillin-eosin ×400). (C): monilethrix. (D): negative expression of desmoplakin in case 4 (×200). 
(E): weak expression of desmoplakin in case 6 (×200). 
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term ‘fingerprint sign’ has been proposed (Figure 2). In addition, papillomatosis, dysker-
atosis, transition cells, pale cytoplasm and cytoplasmic eosinophilic globules were absent. 
Figure 1. Main findings in the immunohistochemistry study. (A): acantholytic areas evidenced in
case 9 (Hematoxylin-Eosin ×200). (B): Acantholytic round cells. Some desmosomes (spines) are
still observe between the round cells and adjacent keratinocytes (hematocillin-eosin ×400). (C):
monilethrix. (D): negative expression of desmoplakin in case 4 (×200). (E): weak expression of
desmoplakin in case 6 (×200).J. Clin. Med. 2021, 10, x FOR PEER REVIEW 7 of 13  
 
 
Figure 2. The fingerprint sign. Keratinocytes with striated cytoplasm (Hematoxylin-Eosin ×1000). 
3.3. Trichogram 
All trichogram findings are summarized in the Table A2 of Appendix B. Some pa-
tients showed a prominent shift towards catagen/telogen. There was no hair shaft dyspla-
sia or cuticular defects. However, seven showed non-uniform thickness of hair shafts and 
pseudomonilethrix (Figure 1C). 
3.4. Immunohistochemistry 
The expression of Plakoglobin, Filamin C and Connexin 43 in the skin biopsies was 
normal (Table 2). However, most of the patients showed negative results for desmoplakin 
expression (Figure 1D) and only three of them (1, 5 and 6) showed weak expression (Fig-
ure 1E). 
3.5. Transmission Electron Microscopy 
In transmission electron microscopy analysis of skin biopsies, 50% of patients 
showed that keratinocytes of the spinous layer had a normal structure, characterized by a 
polygonal/elongated morphology with abundant bundles of tonofilaments (keratin fila-
ments) in the cytoplasm, sometimes associated with masses of keratohyalin (Figure 3A). 
In these samples, desmosomes showed normal ultrastructural features with the presence 
of undisturbed electron-dense midline, inner plaques and keratin filament junctions (Fig-
ure 3B). For the other 50% of patients, ultrastructural analysis of the spinous layer showed 
an enlargement of the intercellular space between keratinocytes and an increase in the 
length of the cytoplasmic bridges (Figure 3C,D), as was found in the histological analysis 
of the samples. In these cases, a decrease in the number of desmosomes was observed, 
although they showed an unaffected structure (Figure 3E). 
Figure 2. The fingerprint sign. Keratinocytes with striated cytoplasm (Hematoxylin-Eosin ×1000).
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3.5. Transmission Electron Microscopy
In transmission electron microscopy analysis of skin biopsies, 50% of patients showed
that keratinocytes of the spinous layer had a normal structure, characterized by a polygo-
nal/elongated morphology with abundant bundles of tonofilaments (keratin filaments)
in the cytoplasm, sometimes associated with masses of keratohyalin (Figure 3A). In these
samples, desmosomes showed normal ultrastructural features with the presence of undis-
turbed electron-dense midline, inner plaques and keratin filament junctions (Figure 3B).
For the other 50% of patients, ultrastructural analysis of the spinous layer showed an
enlargement of the intercellular space between keratinocytes and an increase in the length
of the cytoplasmic bridges (Figure 3C,D), as was found in the histological analysis of the
samples. In these cases, a decrease in the number of desmosomes was observed, although
they showed an unaffected structure (Figure 3E).
Figure 3. Main findings in the electron microscope study. (A): keratinocytes of the spinous layer with abundant keratin
filaments in cytoplasm. (B): keratinocytes with normal ultrastructural features (electron-dense midline, inner plaques and
keratin filament junctions). (C): enlargement of the intercellular space between keratinocytes. (D): increase in the length of
the cytoplasmic bridges. (E): Keratinocytes with unaffected structure.
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4. Discussion
Truncating variants in DSP have repeatedly been related with a high penetrance
cardiac syndrome with left ventricular fibrofatty replacement, predisposition to malignant
arrhythmias and sudden cardiac death [12–15]. The Carvajal Syndrome reflects a recessive
inheritance pattern with clinical affection of DSP not only at the cardiac level, but also
affecting the skin. A major hallmark of the disease pathophysiology is the presence of cell
death leading to fibrosis, predominantly at the epicardium. This location has classically
made it difficult to obtain pathological samples to observe typical AC changes. The
presence of cutaneous involvement when these variants are present in heterozygosis has
previously been reported is small studies, but the real prevalence of skin and ultrastructural
underlying cellular changes is yet to be described. Our study confirms the existence of a
non-clinically relevant cutaneous phenotype, but in the presence of a highly depletion (or
even complete absence) of DSP at the cutaneous level. We have been able to describe novel
and potentially very specific cutaneous DSP changes that might be useful for the diagnosis
and follow up, as they may mirror ultrastructural changes of the heart. These changes may
help, as well, in the interpretation of variants of uncertain significance in DSP in patients
with AC.
Compared to previous publications [9], in our cohort the macroscopic skin findings
are not apparent, but the differences observed in skin homeostasis, with lower temperature
and greater transepidermal water loss (TEWL), which had not been described until now,
are noteworthy. High TEWL values are related with some skin diseases, such as atopic der-
matitis or psoriasis [16]. So, our results might be reflecting subclinical skin impairment in
AC patients. On the contrary, Maruthappu et al., found a fully penetrant cardio-cutaneous
syndrome in heterozygous DSP loss of function mutation carriers [9]. These differences
may reflect a different spectrum of DSP mutations, as their families carried variants af-
fecting both DSP isoforms, while ours affected predominantly the cardiac isoform (DSP I).
It is likely that our population represent in a better way the real-world AC-DSP-related
patients, and we have provided evidence of ultrastructural changes in cell-cell adhesion
that might have clinical implications in the future.
The histopathological changes evidenced in Carvajal syndrome and Naxos disease
are usually described in the literature as epidermolysis with dyskeratosis and epidermal
pseudospongiosis, respectively [17,18]. However, it is difficult to find a more accurate
description with detailed histopathologic imaging. In fact, several of the most relevant
studies on these conditions do not show the cutaneous histopathological findings [19–22].
Our patients showed negative (or almost negative) results in the immunohistochemical
expression of desmoplakin. Since desmoplakin is located in the central part of the desmoso-
mal plaque, it is not surprising that disruption in the protein lead to the observed findings:
widening of the interepidermal space and eventual acantholytic foci [23]. A similar decrease
in DSP expression has been involved in other acantholytic conditions, such as acantholytic
squamous cell carcinoma [24], Hailey-Hailey disease [25], Darier’s disease [25], or epider-
molysis bullosa [26]. In contrast, desmoplakin is not decreased (even in acantholytic cells)
in the case of autoimmune acantholysis [25]. Winik et al. published very interesting results
in two children with acantholytic ectodermal dysplasia. Their histopathological findings
shown by electron microscopy are very similar to ours, with widening of the intercellular
spaces between adjacent keratinocytes [18]. However, in our study those observations are
accompanied by an atypical appearance of the keratinocytes with a striated cytoplasm,
which we have termed the fingerprint sign. All these observations can be explained by the
altered function of cellular desmosomes that may be caused by the truncation of DSP. It is
particularly interesting that other series of heterozygous patients with pathogenic variants
in DSP do not show a reduction in DSP expression in the skin, but only alterations in the
distribution of plakoglobin and connexin 43 [9].
On the other hand, a very high prevalence of pseudomonilethrix was observed, which
did not correlate with a curly hair phenotype that was highly prevalent in the previously
mentioned study [9].
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We found no differences in cutaneous and hair involvement between borderline and
silent carriers compared to those who met definitive diagnostic criteria for AC. According to
Table 2, the three silent carriers and the patient with a borderline diagnosis showed the same
features as those with a definitive diagnosis, including a widening of the intercellular spaces
of the keratinocytes, a striated appearance of the keratinocyte cytoplasm (‘fingerprint sign’)
and a significant reduction of desmoplakin in the immunohistochemical study. Concerning
the study of hair samples, one of the silent carriers showed pseudomonilethrix, while
the other two did not. The sample from the patient with borderline diagnosis could not
be taken.
These findings suggest that the cutaneous–pilose involvement in these patients is
independent of the degree of cardiac involvement, which could be particularly helpful in
the diagnosis in early stages of the disease or when cardiac tests are inconclusive.
5. Conclusions
Regardless of cardiac involvement, heterozygous patients with AC and truncation-
type variants in DSP present lower skin temperature and higher transepidermal water loss,
constant microscopic cutaneous findings and hair shaft involvement (pseudomonilethrix)
with specifical patterns such as the “fingerprint sign”, in the absence of relevant clini-
cally cutaneous findings. Although studies with larger cohorts are needed, as there are
notable differences from the findings published before, these results open the possibil-
ity to include the skin and hair study as a marker of the disease even in the absence of
cardiocutaneous affection.
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Appendix A









System Manufacturer Isotype Type
Identification
Number Clone
Plakoglobin 1/1000 30 Low Flex BioNova IgG1 Monoclonal A303-717A 3728
Desmoplakin 1/25 30 Low Flex PROGEN IgG1 Monoclonal 61003 DP1 +2-2.15
Conexin 43 1/400 30 Low Flex SigmaAldrich IgG1 Monoclonal 045M4882V C6219










Figure A1. Example of cardiac phenotype of included patients. (A): Pedigree of family according to the carrier status of 
the p.Arg2284* desmoplakin gene variant. Males and females are marked with squares and circles, respectively. Mutation 
carriers are marked with (E1-/+) and non-carriers with (E1-/-). Deceased individuals are annotated by a slash. Proband is 
indicated with black arrow. (B) and (C): classic ECG and CMR abnormalities for DSP gene carriers are illustrated (cases 
III-2 and III-7, respectively). The ECG (B) is characterized by low voltages and inverted/flattened T-waves. CMR demon-
strates extensive circumferential subepicardial late gadolinium enhancement (C). (D): Non-sustained ventricular tachy-
cardia (case III.2) during cardiopulmonary exercise testing. 


















1 * a a a a a a a 
2 0/100 
Pseudomonile-
thrix No No No Yes None 
3 100/0 
Pseudomonile-







Yes No Yes No White hairs 
5 40/60 Pseudomonile-
thrix 
Yes No No No None 
6 90/10 No No No No No None 
Figure A1. Example of cardiac phenotype of included patients. (A): Pedigree of family according to the carrier status of
the p.Arg2284* desmoplakin gene variant. Males and females are marked with squares and circles, respectively. Mutation
carriers are marked with (E1-/+) and non-carriers with (E1-/-). Deceased individuals are annotated by a slash. Proband is
indicated with black arrow. (B) and (C): classic ECG and CMR abnormalities for DSP gene carriers are illustrated (cases III-2
and III-7, respectively). The ECG (B) is characterized by low voltages and inverted/flattened T-waves. CMR demonstrates
extensive circumferential subepicardial late gadolinium enhancement (C). (D): Non-sustained ventricular tachycardia (case
III.2) during cardiopulmonary exercise testing.


















1 * a a a a a a a
2 0/100 Pseudomonilethrix No No No Yes None







Yes No Yes No White hairs
5 40/60 Pseudomonilethrix Yes No No No None
6 90/10 No No No No No None
7 0/100 Pseudomonilethrix Yes No No No None
8 80/20 No No No No No White hairs
9 20/80 (smallsample) No No No No No None
10 95/5 No No No No No None
11 0/100 Pseudomonilethrix No No No No White hairs
12 98/2 Pseudomonilethrix Yes No No No None
* In patient 1 it was not possible to take a hair draft.
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